These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32409664)

  • 1. HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo.
    Sanna S; Esposito S; Masala A; Sini P; Nieddu G; Galioto M; Fais M; Iaccarino C; Cestra G; Crosio C
    Cell Death Dis; 2020 May; 11(5):369. PubMed ID: 32409664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
    Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
    Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration.
    Wils H; Kleinberger G; Janssens J; Pereson S; Joris G; Cuijt I; Smits V; Ceuterick-de Groote C; Van Broeckhoven C; Kumar-Singh S
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3858-63. PubMed ID: 20133711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.
    Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM
    Acta Neuropathol Commun; 2017 Oct; 5(1):76. PubMed ID: 29078806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).
    Bentmann E; Neumann M; Tahirovic S; Rodde R; Dormann D; Haass C
    J Biol Chem; 2012 Jun; 287(27):23079-94. PubMed ID: 22563080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death.
    Xiao S; Sanelli T; Chiang H; Sun Y; Chakrabartty A; Keith J; Rogaeva E; Zinman L; Robertson J
    Acta Neuropathol; 2015 Jul; 130(1):49-61. PubMed ID: 25788357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
    Takeda T
    Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC1 dysregulation induces aberrant cell cycle and DNA damage in progress of TDP-43 proteinopathies.
    Wu CC; Jin LW; Wang IF; Wei WY; Ho PC; Liu YC; Tsai KJ
    EMBO Mol Med; 2020 Jun; 12(6):e10622. PubMed ID: 32449313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice.
    Igaz LM; Kwong LK; Lee EB; Chen-Plotkin A; Swanson E; Unger T; Malunda J; Xu Y; Winton MJ; Trojanowski JQ; Lee VM
    J Clin Invest; 2011 Feb; 121(2):726-38. PubMed ID: 21206091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.
    Maekawa S; Leigh PN; King A; Jones E; Steele JC; Bodi I; Shaw CE; Hortobagyi T; Al-Sarraj S
    Neuropathology; 2009 Dec; 29(6):672-83. PubMed ID: 19496940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
    JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration.
    Wegorzewska I; Bell S; Cairns NJ; Miller TM; Baloh RH
    Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18809-14. PubMed ID: 19833869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms Associated with TDP-43 Neurotoxicity in ALS/FTLD.
    Shenouda M; Zhang AB; Weichert A; Robertson J
    Adv Neurobiol; 2018; 20():239-263. PubMed ID: 29916022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS.
    Al-Sarraj S; King A; Troakes C; Smith B; Maekawa S; Bodi I; Rogelj B; Al-Chalabi A; Hortobágyi T; Shaw CE
    Acta Neuropathol; 2011 Dec; 122(6):691-702. PubMed ID: 22101323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [FTLD/ALS as TDP-43 proteinopathies].
    Ishihara T; Ariizumi Y; Shiga A; Yokoseki A; Sato T; Toyoshima Y; Kakita A; Takahashi H; Nishizawa M; Onodera O
    Rinsho Shinkeigaku; 2010 Nov; 50(11):1022-4. PubMed ID: 21921552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reappraisal of the anatomical spreading and propagation hypothesis about TDP-43 aggregation in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Riku Y
    Neuropathology; 2020 Oct; 40(5):426-435. PubMed ID: 32157757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid.
    Bigio EH; Wu JY; Deng HX; Bit-Ivan EN; Mao Q; Ganti R; Peterson M; Siddique N; Geula C; Siddique T; Mesulam M
    Acta Neuropathol; 2013 Mar; 125(3):463-5. PubMed ID: 23378033
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical and pathological spectrum of TDP-43 associated ALS].
    Onodera O; Yokoseki A; Tan CF; Ishihara T; Nishiira Y; Toyoshima Y; Kakita A; Nishizawa M; Takahashi H
    Rinsho Shinkeigaku; 2010 Nov; 50(11):940-2. PubMed ID: 21921519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TDP-43 and FUS: a nuclear affair.
    Dormann D; Haass C
    Trends Neurosci; 2011 Jul; 34(7):339-48. PubMed ID: 21700347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-associated mutations of TDP-43 promote turnover of the protein through the proteasomal pathway.
    Araki W; Minegishi S; Motoki K; Kume H; Hohjoh H; Araki YM; Tamaoka A
    Mol Neurobiol; 2014 Dec; 50(3):1049-58. PubMed ID: 24477737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.